A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

Clinical trial NCT04498650 · COMPLETED

Trial details

NCT number: NCT04498650
Sponsor: Vivoryon Therapeutics N.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Early Alzheimers Disease Mild Cognitive Impairment Due to AD

Start date: 2020-07-06
Primary completion: 2023-12-18
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.